Drug Profile
Latanoprost/timolol - Sun Pharma Advanced Research Company
Alternative Names: Latanoprost 0.005%/Timolol 0.5%; Latocom; Timolol/latanoprost - Sun Pharma Advanced Research CompanyLatest Information Update: 03 Jul 2019
Price :
$50
*
At a glance
- Originator Sun Pharma Advanced Research Company
- Class Amino alcohols; Antiglaucomas; Antihypertensives; Eye disorder therapies; Morpholines; Propanolamines; Prostaglandins; Small molecules; Thiadiazoles
- Mechanism of Action Beta-adrenergic receptor antagonists; Prostaglandin F2 alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Glaucoma
Most Recent Events
- 03 Jul 2019 Chemical structure information added
- 04 Nov 2017 No recent reports of development identified for phase-I development in Glaucoma in USA (Ophthalmic, Drops)